ORIENTBIO Inc.

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It produces, exports, imports, and conducts life science-related research and development of laboratory animals, and offers equipment for research environments. The company also provides infrastructure solutions, health checking, genetic and molecular biological testing, genetic transformation, phenotyping, preconditioning, surgical treatment, transgenic services, eggs and avian research, husbandry support services, diagnostics and kits, claim management, serology reagents, biological materials for new drug development, and antibody production testing for mice, rats, and hamsters. In addition, it is involved in automotive and automobile parts production and sales, preclinical and clinical trial agency services, pharmaceuticals manufacturing and trade, watch manufacturing, processing, wholesaling and retailing, and construction works. It has strategic partnerships with ELLEGARD in the Netherlands and CSIMC in China, and serves research institutions, pharmaceutical companies, and healthcare providers. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. It was founded in 1959 and is headquartered in Seongnam-si, South Korea.